Northwest Biotherapeutics, Inc. Stock
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1900 USD | +0.43% |
|
-0.52% | -16.91% |
| 05-15 | Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04-21 | Northwest Biotherapeutics Establishes Dedicated Leukapheresis Clinic | CI |
| Market Cap | 315M 272M 250M 235M 442M 29.75B 446M 2.96B 1.15B 14.6B 1.18B 1.16B 50.5B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 411M 355M 326M 307M 577M 38.81B 582M 3.87B 1.5B 19.05B 1.54B 1.51B 65.9B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.3x |
| Free-Float |
95.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.43% | ||
| 1 week | -0.52% | ||
| Current month | -16.07% | ||
| 1 month | -24.71% | ||
| 3 months | -4.95% | ||
| 6 months | -20.79% | ||
| Current year | -16.91% |
| 1 week | 0.18 |  | 0.2 |
| 1 month | 0.18 | | 0.26 |
| Current year | 0.18 | | 0.34 |
| 1 year | 0.18 | | 0.37 |
| 3 years | 0.17 | | 1.09 |
| 5 years | 0.17 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 2007-05-31 |
Linda Powers
CEO | Chief Executive Officer | 71 | 2011-06-07 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 1999-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 1997-12-31 |
Linda Powers
CHM | Chairman | 71 | 2007-05-16 |
Navid Malik
BRD | Director/Board Member | 57 | 2012-03-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-08-28 | Don | Founder | 1,000,000 | 0.0826% | ||
| 24-08-08 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 24-08-07 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.43% | -0.52% | -29.23% | -70.29% | 315M | |
| +0.59% | +1.19% | +65.99% | +117.94% | 56.24B | |
| +0.04% | +1.20% | +47.67% | +36.75% | 43.76B | |
| +3.04% | +7.05% | -12.15% | -18.06% | 23.32B | |
| +3.07% | +7.15% | -1.82% | +392.25% | 21.34B | |
| +2.75% | +2.47% | +23.46% | -34.30% | 15.75B | |
| +1.56% | +2.57% | +17.05% | -37.24% | 15.6B | |
| +0.65% | -0.27% | +26.80% | +174.70% | 13.18B | |
| +2.58% | +4.92% | +20.78% | - | 12.01B | |
| +1.92% | +2.43% | +112.68% | +232.59% | 11.87B | |
| Average | +1.66% | +2.79% | +27.12% | +88.26% | 21.34B | |
| Weighted average by Cap. | +1.41% | +2.96% | +37.69% | +99.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 33.59M 30.88M 29.07M 54.62M 3.67B 55.08M 366M 142M 1.8B 146M 143M 6.24B |
| Net income | - | - |
| Net Debt | 96.08M 82.89M 76.21M 71.73M 135M 9.07B 136M 903M 352M 4.45B 361M 353M 15.39B | 125M 108M 99.09M 93.27M 175M 11.79B 177M 1.17B 457M 5.79B 469M 459M 20.02B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-17 | 0.1900 $ | +0.43% | 2,768,029 |
| 26-06-16 | 0.1892 $ | -0.40% | 2,033,892 |
| 26-06-15 | 0.1900 $ | -5.23% | 1,412,437 |
| 26-06-12 | 0.2005 $ | +7.17% | 2,918,579 |
| 26-06-11 | 0.1871 $ | -2.09% | 2,870,337 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1900USD
Average target price
1.000USD
Spread / Average Target
+426.18%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
